Fisher Asset Management LLC Buys New Stake in Cardinal Health, Inc. (NYSE:CAH)

Fisher Asset Management LLC bought a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,107 shares of the company's stock, valued at approximately $368,000.

A number of other hedge funds have also made changes to their positions in CAH. Frazier Financial Advisors LLC grew its holdings in Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock valued at $28,000 after buying an additional 104 shares during the last quarter. Hara Capital LLC purchased a new stake in shares of Cardinal Health in the third quarter valued at $31,000. AM Squared Ltd acquired a new stake in shares of Cardinal Health during the third quarter valued at $33,000. Kentucky Trust Co purchased a new stake in Cardinal Health during the 4th quarter worth about $41,000. Finally, HHM Wealth Advisors LLC raised its stake in Cardinal Health by 57.6% in the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after purchasing an additional 144 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Trading Down 2.0 %

NYSE CAH traded down $2.51 during trading hours on Monday, reaching $123.99. The company's stock had a trading volume of 192,018 shares, compared to its average volume of 2,376,640. The stock has a market cap of $29.95 billion, a PE ratio of 23.10, a PEG ratio of 1.49 and a beta of 0.66. The business has a 50-day simple moving average of $125.58 and a 200 day simple moving average of $118.88. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.63%. Cardinal Health's dividend payout ratio is presently 37.69%.

Analysts Set New Price Targets

CAH has been the subject of a number of analyst reports. JPMorgan Chase & Co. boosted their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Mizuho started coverage on Cardinal Health in a research report on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 target price for the company. Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and raised their target price for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Morgan Stanley boosted their price target on Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Finally, Bank of America upgraded shares of Cardinal Health from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.